Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Research Advisory Panel topic
No spam. Unsubscribe anytime.
Board appoints Dr. Kelly Lee to state Research Advisory Panel for three-year term
Summary
The California State Board of Pharmacy announced the appointment of Dr. Kelly Lee as the board's representative to the Research Advisory Panel of California under Health and Safety Code section 11480 for a three-year term and requested annual reports to the board.
The California State Board of Pharmacy advised members that it has appointed Dr. Kelly Lee to serve as the board’s representative on the Research Advisory Panel of California, established by Health and Safety Code section 11480 to authorize and review research into cannabis and hallucinogenic drugs. The appointment runs for three years.
Board leadership said that historically the board’s appointment to the panel was served until retirement; the current appointment was made for a fixed three-year term, and the appointer asked Dr. Lee to present annually to the board so members can monitor the panel’s work. No board action was required on the appointment.
No public comments on the appointment were received during the item’s public-comment period.
The board did not set additional duties beyond the appointment and the request for an annual presentation.
